Relevium Medical

RheaVita is a pharmaceutical company developing continuous freeze-drying technology for biopharmaceutical products.

Operator of a retinal therapeutics company intended to offer retinal disease treatment. The company provides tissue-specific delivery of potent drug products to address multiple pathophysiological pathways of retinal diseases such as age-related macular degeneration, diabetic macular edema, retinal vein occlusion, and cystoid macular edema, enabling patients to increase the cure's effectiveness, reduce its side effects and minimize the frequency of their retinal treatments.

Operator of a medical technology company intended to develop medical technologies to address major unmet clinical needs in orthopedics. The company specializes in developing InDx implant and Osteoanchor surface architecture that is created on evidence-based designs, enabling clinicians to meet unmet clinical needs in orthopedics extremities space.